Navigation Links
NIH EUREKA award funds research at WPI aimed at turning adult skin cells into stem-like cells
Date:9/3/2008

hensive study of the contents of the Xenopus extract, systematically searching for specific componentsparticularly proteins, RNAs, and micro-RNAsthat may be responsible for its ability to induce pluripotency in adult cells. They will test components by exposing adult skin cells to selected fractions of the extract and then looking for the genetic markers of pluripotency. Treated cells will also be tested for their ability to form all three of the germ layers that develop early in the formation of an embryo. The germ layers go on to form all of the many tissue types in the body. This is a commonly accepted test for pluripotency.

Dominko says the ultimate goal of the NIH project is to identify and characterize components of the Xenopus extract that can induce pluripotency in adult cells. "A fully differentiated adult cell, whether a muscle cell, a liver cell, or a neuron, retains its 'memory' of its embryonic state," she says. "We want to find a way to chemically erase the adult cell memory and revive the embryonic memory, so the cells regain the ability to become any type of cell."

Newly pluripotent adult cells could be put to the same uses now being identified for embryonic and adult stem cells, but would avoid the most serious problems associated with those cell types. For example, patients receiving a transplant derived from embryonic stem cells would need to take a lifelong regime of immunosuppressive drugs to avoid rejection. The need for immunosuppressive drugs could be avoided by using a patient's own adult stem cells, but these cells are difficult to obtain and have limited ability to regenerate tissue after being grown in the lab. Recent advances in using transgenic techniques to transform adult cells into stem cells carry the risk that the resulting cells could grow into tumors, a concern also associated with embryonic stem cells.

"In preliminary work, we have shown that cells induced to pluripotency with Xenopus extract have a mu
'/>"/>

Contact: Michael Dorsey
mwdorsey@wpi.edu
508-831-5609
Worcester Polytechnic Institute
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. C. Erec Stebbins awarded prestigious EUREKA grant
2. Broad Institute awarded grant to develop chemical probes for human biology and disease
3. Prominent German biologist wins EMBO Communication Award
4. Kalyon wins Society of Plastics Engineers 2008 Research Award
5. $2M grant awarded to University of Kentucky for research on nanoparticles and human health
6. Caltech researchers awarded $10M for molecular programming project
7. Clemson bioengineer wins prestigious Early Career Award
8. UCSB chemistry professor receives top military award for life-saving gauze
9. Springer editor Toshisada Nishida winner of 2 prestigious primatology awards
10. Dartmouth awarded NSF grant for new polar sciences, engineering grad program
11. LSUHSCs Lazartigues awarded $1.2 million grant
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):First phase of pan-tropical forest mapping debuting at COP15 2First phase of pan-tropical forest mapping debuting at COP15 3Nanomedicine: Ending 'hit and miss' design 2Nanomedicine: Ending 'hit and miss' design 3Physical education teaching staff play key role in making you like sport 2QLT announces positive results from the evaluation of Visudyne 28R 29 combination therapy 47591 1QLT announces positive results from the evaluation of Visudyne 28R 29 combination therapy 47591 2QLT announces positive results from the evaluation of Visudyne 28R 29 combination therapy 47591 3QLT announces positive results from the evaluation of Visudyne 28R 29 combination therapy 47591 4QLT announces positive results from the evaluation of Visudyne 28R 29 combination therapy 47591 5QLT announces positive results from the evaluation of Visudyne 28R 29 combination therapy 47591 6QLT announces positive results from the evaluation of Visudyne 28R 29 combination therapy 47591 7Express Scripts Launches Equity Offering to Finance Acquisition 47588 1Express Scripts Launches Equity Offering to Finance Acquisition 47588 2Express Scripts Launches Equity Offering to Finance Acquisition 47588 3Leading North American Emergency Medical Services Provider British Columbia Ambulance Service Selects NICE Inform for Improved Service 12409 1Leading North American Emergency Medical Services Provider British Columbia Ambulance Service Selects NICE Inform for Improved Service 12409 2Leading North American Emergency Medical Services Provider British Columbia Ambulance Service Selects NICE Inform for Improved Service 12409 3Leading North American Emergency Medical Services Provider British Columbia Ambulance Service Selects NICE Inform for Improved Service 12409 4Leading North American Emergency Medical Services Provider British Columbia Ambulance Service Selects NICE Inform for Improved Service 12409 5
Other Biology Technology:HTRF IP-One Assay Performed on the PHERAstar and RUBYstar Plate Readers 2HTRF IP-One Assay Performed on the PHERAstar and RUBYstar Plate Readers 3HTRF IP-One Assay Performed on the PHERAstar and RUBYstar Plate Readers 4HTRF IP-One Assay Performed on the PHERAstar and RUBYstar Plate Readers 5HTRF IP-One Assay Performed on the PHERAstar and RUBYstar Plate Readers 6 New Automated Yeast Cell Counter Ends Tedium & Errors of Manual Counting 2The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 2The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 3The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 4The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 5The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 6The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 7The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 8The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 9The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 10